Use of KW-2189, a DNA Minor Groove-Binding Agent, in Patients with Hepatocellular Carcinoma: A North Central Cancer Treatment Group (NCCTG) Phase II Clinical Trial-Reference-Cited by-同舟云学术

Use of KW-2189, a DNA Minor Groove-Binding Agent, in Patients with Hepatocellular Carcinoma: A North Central Cancer Treatment Group (NCCTG) Phase II Clinical Trial

Published:2007-01 Issue:1 Volume:38 Page:10-14
ISSN:1941-6628
Container-title:Journal of Gastrointestinal Cancer
language:en
Short-container-title:J Gastrointest Canc

Author:

Alberts Steven R.,Suman Vera J.,Pitot Henry C.,Camoriano John K.,Rubin Joseph

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s12029-007-9007-6.pdf

Reference27 articles.

1. Mor E, Kaspa RT, Sheiner P, Schwartz M. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med. 1998;129:643–53.

2. Simonetti RG, Liberati A, Angiolini C, Pagliaro L. Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol. 1997;8:117–36.

3. Ichimura M, Ogawa T, Katsumata S, Takahashi K-I, Takahashi I, Nakano H. Duocarmycins, new antitumor antibiotics produced by Streptomyces; producing organisms and improved production. J Antibiotics. 1991;44:1045–53.

4. Ichimura M, Ogawa T, Takahashi K-I, Kobayashi E, Kawamoto I, Yasuzawa T, et al. Duocarmycin SA, a new antitumor antibiotic from Streptomyces sp. J Antibiotics. 1990;43:1037–8.

5. Ogawa T, Ichimura M, Katsumata S, Morimoto M, Takahashi K. New antitumor antibiotics, duocarmycins B1 and B2. J Antibiotics. 1989;42:1299–301.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticancer drugs that interact with the DNA minor groove;Medicinal Chemistry of Anticancer Drugs;2023

2. Duocarmycin-based antibody–drug conjugates as an emerging biotherapeutic entity for targeted cancer therapy: Pharmaceutical strategy and clinical progress;Drug Discovery Today;2021-08

3. Bifunctional Duocarmycin Analogues as Inhibitors of Protein Tyrosine Kinases;Journal of Natural Products;2019-01-08

4. The Chemical Design and Synthesis of Linkers Used in Antibody Drug Conjugates;Current Topics in Medicinal Chemistry;2018-02-23

5. First-in-human multicenter phase I study of BMS-936561 (MDX-1203), an antibody-drug conjugate targeting CD70;Cancer Chemotherapy and Pharmacology;2015-11-14